Canadian Bleeding Disorders Registry (CBDR) Platform System Build
Solicitation number CR 01-26-1111
Publication date
Closing date and time 2026/06/09 14:00 EDT
Description
McMaster University invites qualified vendors to submit proposals for the comprehensive modernization of the Canadian Bleeding Disorders Registry (CBDR) including the design, development, implementation, and ongoing support of a new CBDR platform . This national healthcare registry serves approximately 15,000 patients across 26+ Hemophilia Treatment Centres (HTCs) throughout Canada. The CBDR project encompasses three integrated components: (1) CBDR Core Module for clinical registry functions, (2) MyCBDR Unified Application for patient engagement across web, iOS, and Android platforms, and (3) CBDR-R Research Platform for clinical and academic research studies. The system must comply with The Personal Information Protection and Electronic Documents Act (PIPEDA), Personal Health Information Protection Act (PHIPA), and applicable provincial privacy legislation, with mandatory Canadian data residency.
The scope of this RFP includes the complete design, development, testing, deployment, data migration, training, and ongoing support of the CBDR system. The successful Proponent will deliver a modern, cloud-native platform that replaces the current legacy CBDR system while maintaining all existing functionality and adding new capabilities including gene therapy monitoring per World Federation of Hemophilia Gene Therapy Registry (WFH GTR) protocol, enhanced patient engagement features, and a dedicated research platform. Key deliverables include: CBDR Core Module with full clinical registry capabilities; MyCBDR unified patient application (web, iOS, Android) with offline capability; CBDR-R research platform with custom form builder; integration with external systems (WAPPS-Hemo, PROBE, CBS, Héma-Québec); comprehensive data migration from the existing system; bilingual support (English/French); and WCAG 2.1 AA accessibility compliance.
The scope of this RFP includes the complete design, development, testing, deployment, data migration, training, and ongoing support of the CBDR system. The successful Proponent will deliver a modern, cloud-native platform that replaces the current legacy CBDR system while maintaining all existing functionality and adding new capabilities including gene therapy monitoring per World Federation of Hemophilia Gene Therapy Registry (WFH GTR) protocol, enhanced patient engagement features, and a dedicated research platform. Key deliverables include: CBDR Core Module with full clinical registry capabilities; MyCBDR unified patient application (web, iOS, Android) with offline capability; CBDR-R research platform with custom form builder; integration with external systems (WAPPS-Hemo, PROBE, CBS, Héma-Québec); comprehensive data migration from the existing system; bilingual support (English/French); and WCAG 2.1 AA accessibility compliance.
Bidding and Documents are available on http://www.merx.com. Fees may apply; See https://www.merx.com/public/pricing for more information.
Contract duration
The estimated contract period will be 24 month(s).
Trade agreements
-
Canadian Free Trade Agreement (CFTA)
-
Canada-European Union Comprehensive Economic and Trade Agreement (CETA)
-
Please refer to tender description or tender documents
Contact information
Contracting organization
- Organization
-
McMaster University
- Address
-
1280 Main Street WestHamilton, Ontario, L8S 4L8Canada
- Contracting authority
- Carol Rizzo
- Phone
- 905-525-9140
- Email
- rizzoc2@mcmaster.ca
Bidding details
Full details for this tender opportunity are available on a third-party site
Click on the button below to be directed to this website. Note that on the third-party site you may need an account to view and/or bid on this tender. Information on any fees or additional costs to access the full details is outlined in the Description tab of this tender opportunity.